Davipharm – A 20-year journey from humble beginnings to a trend-setting pioneer.
Established in 2004 with a manufacturing plant in Binh Duong , Davipharm – a member of the Adamed Group – has grown from a small business into one of Vietnam's leading pharmaceutical companies.
Achievements of the sales and marketing team
Starting with an exclusive distribution channel, Davipharm established a sales team through retail and hospital systems in June 2020. From an early team of only 6 members, it grew to 130 members by 2024, including Sales, Marketing, and Medical teams. In 2020, Davipharm only reached about 100 pharmacies; now, the company's products are available in 12,000 pharmacies nationwide.
 |
| Davipharm expands its business focus with a strong sales team. |
What sets Davipharm apart in the industry is its commitment to providing high-quality products that meet EU-GMP standards, and its technology transfer from Adamed Pharma – one of Poland's leading pharmaceutical and biotechnology companies. Combined with flexible and professional services tailored to customer needs, Davipharm has created a competitive advantage in the market.
Amidst the race to build EU-GMP-compliant factories, the trend of mergers between international corporations and domestic pharmaceutical companies, and the renegotiation of drug prices in bidding processes, Davipharm has maintained its pioneering position with high-quality products at affordable prices.
2021 marked a significant milestone for Davipharm with the certification of the first HP Zone in Vietnam specializing in the production of high-activity solid-state drugs, including cancer treatments. In the same year, the company received its first EU-GMP certification, becoming one of the few pharmaceutical companies in Vietnam to achieve this prestigious quality standard.
 |
| Inside the high-activity drug manufacturing area of Davipharm |
2022 marked another notable achievement for Davipharm when it successfully won a national tender, with a total contract value exceeding 700 billion VND. Davipharm's high-quality products and services have earned the trust of healthcare professionals in hospitals and pharmacies nationwide.
According to IQVIA's Q1/2024 report, compared to the same period last year, Davipharm experienced strong growth of 28%, while the Vietnamese pharmaceutical market grew by 7%. For the retail channel, the market grew by 3%, while Davipharm grew by 17%. For the hospital channel, the market grew by 13%, while Davipharm grew by 37%. Marketing activities, increased awareness of high-quality products, and dedicated customer service helped propel Davipharm to 21st place in the pharmaceutical market ranking. Among domestic companies, Davipharm rose to 9th place, and for prescription drugs in hospitals, the company is currently ranked 5th in terms of sales.
Expanding future vision and strategy
In 2024, Davipharm participated in most major scientific conferences organized by associations and hospitals nationwide, reaching over 2,000 doctors. The company also provided disease and product education programs to 6,000 pharmacies and was present at domestic and international pharmaceutical exhibitions.
The newly launched products mainly focus on cardiovascular health, diabetes, and men's health. Davipharm introduced the website themlauthemdamsau.com, which helps patients self-assess their men's health status, receive advice via hotline, and order prescription medications online. For the distribution channel, new features have also been developed, such as registration for long-term loyalty programs, sales tracking, and estimated customer rewards.
In collaboration with the Department of Preventive Medicine – Ministry of Health since 2021, the company has been organizing a free screening program for non-communicable diseases at its pharmacies annually. In 2024, the program was implemented in Hanoi, Da Nang, Dak Lak, Nha Trang, Can Tho, and Ho Chi Minh City, with the goal of screening a total of 10,000 patients.
Davipharm has been implementing important strategies and initiatives to enhance its ability to meet the growing market demand. The retail channel aims to introduce Davipharm products into 20,000 pharmacies, with at least 10 products in each pharmacy. For the hospital channel, Davipharm aims to be included in most major product packages in national tenders, becoming the top choice for doctors, providing internationally standardized products at reasonable prices, thereby reducing the financial burden on Vietnamese patients.
With the ambition to become the leading pharmaceutical manufacturer and number one pharmaceutical exporter in Vietnam, Davipharm plans to invest in infrastructure to enhance production and warehousing capacity, and develop 12 new products annually for the international market.
Davipharm's journey over the past 20 years is a testament to its unwavering commitment, teamwork, and flexibility, all working towards a shared vision. These continuous efforts have yielded outstanding achievements, elevating Davipharm to new heights in the pharmaceutical industry.
![[Image] Vietnam's colorful journey of innovation](/_next/image?url=https%3A%2F%2Fvphoto.vietnam.vn%2Fthumb%2F1200x675%2Fvietnam%2Fresource%2FIMAGE%2F2025%2F12%2F14%2F1765703036409_image-1.jpeg&w=3840&q=75)
![[Image] Vietnam's colorful journey of innovation](https://vphoto.vietnam.vn/thumb/402x226/vietnam/resource/IMAGE/2025/12/14/1765703036409_image-1.jpeg)
Comment (0)